Sofia, Bulgaria, June 13, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 12, 2025 the Company sold 5 296  (five thousand two hundred ninety-six) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 35 742.88 on the Bulgarian Stock Exchange, the average price per share was BGN 6.75.

Sofia, Bulgaria, June 12, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 11, 2025 the Company sold 6 200  (six thousand two hundred) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 41 308.00 on the Bulgarian Stock Exchange, the average price per share was BGN 6.66.

Sofia, Bulgaria, June 11, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 10, 2025 the Company sold 21 413 (twenty-one thousand four hundred thirteen) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 138 406.16 on the Bulgarian Stock Exchange, the average price per share was BGN 6.46.